Evidence map›Paper›PMID 38926747›Full record

ArticleAlzheimer's research & therapy2024

Associations of modifiable and non-modifiable risk factors with cognitive functions - a prospective, population-based, 17 years follow-up study of 3,229 individuals.

Isabelle Glans, Katarina Nägga, Anna-Märta Gustavsson, Erik Stomrud, Peter M Nilsson, Olle Melander, Oskar Hansson, Sebastian Palmqvist

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Isabelle GlansClinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden. isabelle.glans@med.lu.se.
Katarina NäggaClinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.
Anna-Märta GustavssonClinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.
Erik StomrudClinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.
Peter M NilssonDepartment of Clinical Science, Lund University, Skåne University Hospital, Malmö, Malmö, Sweden.
Olle MelanderDepartment of Clinical Science, Lund University, Skåne University Hospital, Malmö, Malmö, Sweden.
Oskar HanssonClinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.
Sebastian PalmqvistClinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden. sebastian.palmqvist@med.lu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough several cardiovascular, demographic, genetic and lifestyle factors have been associated with cognitive function, little is known about what type of cognitive impairment they are associated with. The aim was to examine the associations between different risk factors and future memory and attention/executive functions, and their interaction with APOE genotype.

methodsParticipants from a large, prospective, population-based, Swedish study were included (n = 3,229). Linear regression models were used to examine baseline hypertension, body mass index (BMI), long-term glucose levels (HbA

resultsThe mean age at baseline was 56.1 (SD 5.7) years and 59.7% were women. The mean follow-up time was 17.4 (range 14.3-20.8) years. When examining independent effects, APOE ε4 genotype(p < 0.01), and higher HbA

conclusionsTargeting cardiovascular risk factors in mid-life could have greater effect on future attention/executive functions rather than memory, whereas targeting diabetes could be beneficial for multiple cognitive domains. In addition, effects of different risk factors may vary depending on the APOE genotype. The varied cognitive profiles suggest that different mechanisms and brain regions are affected by the individual risk factors. Having detailed knowledge about the specific cognitive effects of different risk factors might be beneficial in preventive health counseling.

Indexed as

Executive FunctionAgedAlcohol DrinkingApolipoprotein E4AttentionBody Mass IndexCognitionCognitive DysfunctionFemaleFollow-Up StudiesGenotypeGlycated HemoglobinHumansMaleMemoryMiddle AgedApolipoprotein E4Glycated Hemoglobin

Identifiers

PMID38926747
PMCPMC11202373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.